1. Home
  2. UXIN vs EOLS Comparison

UXIN vs EOLS Comparison

Compare UXIN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UXIN
  • EOLS
  • Stock Information
  • Founded
  • UXIN 2011
  • EOLS 2012
  • Country
  • UXIN China
  • EOLS United States
  • Employees
  • UXIN N/A
  • EOLS N/A
  • Industry
  • UXIN Business Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UXIN Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • UXIN Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • UXIN 744.3M
  • EOLS 787.7M
  • IPO Year
  • UXIN 2018
  • EOLS 2018
  • Fundamental
  • Price
  • UXIN $4.28
  • EOLS $11.73
  • Analyst Decision
  • UXIN
  • EOLS Strong Buy
  • Analyst Count
  • UXIN 0
  • EOLS 6
  • Target Price
  • UXIN N/A
  • EOLS $22.60
  • AVG Volume (30 Days)
  • UXIN 203.8K
  • EOLS 504.4K
  • Earning Date
  • UXIN 11-25-2024
  • EOLS 11-06-2024
  • Dividend Yield
  • UXIN N/A
  • EOLS N/A
  • EPS Growth
  • UXIN N/A
  • EOLS N/A
  • EPS
  • UXIN N/A
  • EOLS N/A
  • Revenue
  • UXIN $232,096,942.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • UXIN $26.86
  • EOLS $33.43
  • Revenue Next Year
  • UXIN N/A
  • EOLS $32.44
  • P/E Ratio
  • UXIN N/A
  • EOLS N/A
  • Revenue Growth
  • UXIN 11.56
  • EOLS 34.42
  • 52 Week Low
  • UXIN $1.41
  • EOLS $9.65
  • 52 Week High
  • UXIN $8.40
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • UXIN 46.62
  • EOLS 34.39
  • Support Level
  • UXIN $3.91
  • EOLS $11.34
  • Resistance Level
  • UXIN $4.49
  • EOLS $12.99
  • Average True Range (ATR)
  • UXIN 0.52
  • EOLS 0.51
  • MACD
  • UXIN -0.05
  • EOLS -0.03
  • Stochastic Oscillator
  • UXIN 22.50
  • EOLS 13.07

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: